JAC Advance Access published online on September 20, 2002
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkf180
© 2002 by The British Society for Antimicrobial Chemotherapy
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original Paper
1 Centre of Respiratory
Pharmacology, Department of Pharmacology, School of Medicine, University
of Milan,
Via Vanvitelli 32, 20129 Milano
* Corresponding author. E-mail: piercarlo.braga{at}unimi.it.
Received 13 November 2001
; revised 27 May 2002
; accepted 17 July 2002
The aim of this study was to use atomic force microscopy
(AFM), an innovative type of microscopy, to investigate the different
behaviours of erythromycin A (a 14-membered ring) and rokitamycin
(a 16-membered ring) in disrupting the morphology of Streptococcus
pyogenes with the M phenotype. AFM scanning and sensing of
the topography of a sample makes it possible to obtain simultaneous
high-resolution digital measurements of the x, y and z coordinates at any point
on the bacteria surface. The images obtained before and 2, 4 and
6 h after incubation with erythromycin A (32 mg/L) and rokitamycin
(2 mg/L) clearly show that not even high concentrations of erythromycin
A interfere with the M phenotype of S. pyogenes, whereas
rokitamycin has a progressive action that leads to the formation
of abnormally large cells, the loosening of chain structure and
the formation of clusters.
Keywords: atomic force microscopy, Streptococcus
pyogenes M phenotype, erythromycin A, rokitamycin
Differences in the susceptibility of Streptococcus
pyogenes to rokitamycin and erythromycin A revealed by morphostructural
atomic force microscopy
2 Department
of Biophysical Electronic Engineering, University of Genoa, Italy
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. L. Soon, R. L. Nation, P. G. Hartley, I. Larson, and J. Li Atomic Force Microscopy Investigation of the Morphology and Topography of Colistin-Heteroresistant Acinetobacter baumannii Strains as a Function of Growth Phase and in Response to Colistin Treatment Antimicrob. Agents Chemother., December 1, 2009; 53(12): 4979 - 4986. [Abstract] [Full Text] [PDF] |
||||
